Building Insights for Patient Focused Drug Development: Understanding Patient Desires and Barriers
The COVID-19 pandemic continues to revolutionize the role of the patient voice in drug development and clinical trial creation and execution.
The COVID-19 pandemic continues to revolutionize the role of the patient voice in drug development and clinical trial creation and execution.
Patient perspectives on managing chronic condition(s) during the summer can help pharma marketers craft accurate, authentic, and season-specific messaging.
Pharma marketers can harness the power of social media to reach patients where they are through credible, accurate, and engaging online content.
While COVID-19 has impacted people worldwide, there has been a particular focus over the past two years on people who are immunocompromised.
Healthcare industry participation in the 2022 Social Health Awards will lay a strong foundation in emphasizing your commitment to patient centricity.
Health Union’s model of facilitating engagement supports social learning; it creates not just communities, but communities of practice.
Patients are using social health on condition-specific online communities to conceptualize mental health awareness and support.
Health Union survey data reveals trends in social health use by condition, creating opportunities for pharma to reach patients in the moments that matter.
While there are commonalities across the board, the top three resources that provide value for patients vary by therapeutic area and specific condition.
Health Union’s published analysis in the Journal of Medical Internet Research and a recent survey of 2,371 patients demonstrate the value of social health.